Skip to main content
OpenTrials

Clinical trial condition

Thyroid Carcinoma, Anaplastic

Explore clinical trials studying Thyroid Carcinoma, Anaplastic. Study availability and eligibility vary by location and protocol.

55 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Thyroid Carcinoma, Anaplastic trial results

Active, Not Recruiting

Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer (NAVIGATION)

NCT05696548

Conditions
Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +3 more
Locations
  • Aichi Cancer Center Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • Hokkaido University Hospital Hokkaido, Japan
  • Hyogo Cancer Center Akashi, Hyōgo, Japan
View Trial Details
Active, Not Recruiting

Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer

NCT04675710

Conditions
Carcinoma, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations
  • Stanford School of Medicine Stanford, California, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Cleveland Clinic Taussig Cancer Institute Cleveland, Ohio, United States
View Trial Details
Active, Not Recruiting

Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer

NCT04420754

Conditions
Anaplastic Thyroid Cancer, Carcinoma, Disease Attributes, +8 more
Locations
  • City of Hope National Medical Center, City of Hope Medical Center Duarte, California, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • Weill Cornell Medical College New York, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions